| Property | Value |
|---|
| Working Groups |  Hemmer |
| Subproject | None |
| Open Access |  Yes |
| Publication Type | Journal Article |
| Peer Reviewed | Yes |
| PMID |  28002688 |
| DOI |  10.1056/NEJMoa1606468 |
| Publication Year | 2017 |
| Title | Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis.  |
| Journal | The New England journal of medicine |
| ISSN | 0028-4793 |
| ESSN | 1533-4406 |
| URL | https://www.ncbi.nlm.nih.gov/pubmed/?term=28002688%5Buid%5D |
| Pages | 209-220 |
| Issue | 3 |
| Volume | 376 |
| Journal Abbreviation | N Engl J Med |
| Authors | Montalban X, Hauser SL, Kappos L, Arnold DL, Bar-Or A, Comi G, de Seze J, Giovannoni G, Hartung HP, Hemmer B, Lublin F, Rammohan KW, Selmaj K, Traboulsee A, Sauter A, Masterman D, Fontoura P, Belachew S, Garren H, Mairon N, Chin P, Wolinsky JS |
| First Author | Montalban X |
| Last Author | Wolinsky JS |
| Scholia |  Wikidata-based representation at Scholia |
External Resources
Q40400256https://www.wikidata.org/wiki/Q40400256
Wikidata ID
